BioNexus Gene Lab Corp.

BGLC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$2,895$814$3,595$4,377
Short-Term Investments$0$2,245$0$0
Receivables$1,626$2,105$1,768$1,580
Inventory$1,007$1,216$1,179$1,389
Other Curr. Assets$99$0$0$84
Total Curr. Assets$5,627$6,379$6,542$7,430
Property Plant & Equip (Net)$1,757$1,793$1,724$1,738
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$238$1,249$1,213$1,265
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,994$3,042$2,938$3,003
Other Assets$0$0$0$0
Total Assets$7,621$9,421$9,480$10,434
Liabilities
Payables$185$1,368$1,183$1,503
Short-Term Debt$57$56$52$51
Tax Payable$0$0$0$0
Deferred Revenue$11$11$22$96
Other Curr. Liab.$425$323$304$301
Total Curr. Liab.$678$1,758$1,560$1,951
LT Debt$127$141$148$160
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$127$141$148$160
Other Liabilities$0$0$0$0
Cap. Leases$127$197$200$211
Total Liabilities$805$1,899$1,708$2,111
Equity
Pref Stock$0$0$0$0
Common Stock$17,332$17,332$17,332$17,332
Retained Earnings-$5,391-$4,682-$4,066-$3,443
AOCI-$113-$116-$483-$555
Other Equity-$5,012-$5,012-$5,012-$5,012
Total Equity$6,816$7,522$7,772$8,323
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$7,621$9,421$9,480$10,434
Net Debt-$2,711-$617-$3,395-$4,167